ClinicalTrials.govpublic full text
Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
gastric cancer, gastric adenocarcinoma, catumaxomab, neoadjuvant chemotherapy, phase ii, interoperative, trifunctional antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908065
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.